空间转录组学揭示内化自身抗体驱动自身免疫的机制
研究对814例自身免疫病患者及健康对照的肌肉活检进行批量RNA测序,并以41例外部验证样本验证,发现抗Mi2皮肌炎和抗PM/Scl硬化性肌炎具有可重复的自身抗体特异性转录组特征。空间转录组学将上述特征与细胞损伤及不同炎症反应(I型干扰素/TGFβ与II型干扰素)关联,并观察到免疫球蛋白RNA从抗体分泌细胞转移至邻近靶细胞,且抗体内化现象见于多种自身抗体相关疾病及组织。
要点
- 自身抗体特异性转录组特征在抗Mi2皮肌炎和抗PM/Scl硬化性肌炎中可重复验证。
- 空间转录组学揭示抗体内化相关转录程序主要见于肌纤维及巨噬细胞、内皮细胞和成纤维细胞。
- 抗体内化现象见于抗Mi2、抗PM/Scl、抗U1RNP、抗Ku及抗Scl70相关疾病组织。
核心结论
- 自身抗体内化是自身免疫组织损伤的一种机制,可能广泛适用于自身抗体介导的疾病。
研究设计与样本
- 对814例自身免疫病患者及健康对照的肌肉活检行批量RNA测序,并设41例外部验证样本。
- 将纯化患者IgG电穿孔导入原代人细胞以评估体外功能效应。
- 采用免疫荧光评估免疫球蛋白在疾病和组织中的定位,并用空间转录组学评估疾病特异性基因表达、细胞损伤和炎症反应。
主要发现
- 抗Mi2皮肌炎和抗PM/Scl硬化性肌炎具有可重复的自身抗体特异性转录组特征,与自身抗原功能障碍一致。
- 将纯化患者IgG电穿孔导入健康原代细胞可重现这些疾病相关转录程序。
- 空间转录组学将上述特征与细胞损伤及不同炎症反应关联:抗Mi2皮肌炎中I型干扰素和TGFβ信号激活,抗PM/Scl硬化性肌炎中II型干扰素信号激活。
- 上述转录程序主要见于肌纤维,也见于巨噬细胞、内皮细胞和成纤维细胞/纤维脂肪生成祖细胞。
- 空间转录组学揭示免疫球蛋白RNA从抗体分泌细胞转移至表达疾病特异性转录程序的邻近靶细胞。
临床怎么用
- 自身抗体内化机制提示可针对抗体进入细胞后的转录程序探索干预策略。
- 不同自身抗体相关疾病的内化现象及炎症通路差异(如I型与II型干扰素)可为疾病分型和靶向治疗提供依据。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Autoantibody internalisation has been implicated in autoimmune disease pathogenesis, yet its mechanisms and generalisability across diseases, cell types, and tissues remain poorly defined. We sought to address these gaps. METHODS: Bulk RNA sequencing was performed on 814 muscle biopsies from patients with autoimmune diseases and healthy controls, including an external validation cohort of 41 additional samples. Purified patient immunoglobulin (Ig) G was electroporated into primary human cells to assess functional effects in vitro. Immunofluorescence evaluated localisation of immunoglobulins across diseases and tissues. Spatial transcriptomics assessed disease-specific gene expression, cellular injury, and inflammatory responses. RESULTS: Using anti-Mi2 dermatomyositis and anti-PM/Scl scleromyositis as model diseases, we validated reproducible, autoantibody-specific transcriptomic signatures consistent with autoantigen dysfunction across cohorts and confirmed that electroporation of purified patient IgG into healthy primary cells recapitulates these disease-associated transcriptional programmes. Spatial transcriptomics linked these signatures to cellular injury and distinct inflammatory responses, including activation of type I interferon and TGFβ signalling in anti-Mi2 dermatomyositis and type II interferon signalling in anti-PM/Scl scleromyositis. These programmes were observed predominantly not only in muscle fibres but also in macrophages, endothelial cells, and fibroblasts/fibroadipogenic progenitors. Spatial transcriptomics further revealed transfer of immunoglobulin RNA from antibody-secreting cells to adjacent target cells expressing disease-specific transcriptional programmes. Antibody internalisation, previously described in myositis muscle, was also observed in skin from patients with anti-Mi2 and anti-PM/Scl and in tissues from anti-U1RNP mixed connective tissue disease, anti-Ku overlap syndrome, and anti-Scl70 systemic sclerosis. CONCLUSIONS: Together, these findings establish autoantibody internalisation as a mechanism of tissue injury in autoimmunity, suggesting its broader relevance across autoantibody-mediated diseases.
引用
- Pinal-Fernandez I, Pak K, Casal-Dominguez M, et al. Spatial transcriptomics reveals mechanism of autoimmunity driven by internalised autoantibodies. Ann Rheum Dis. 2026. PMID: 42493309. doi:10.1016/j.ard.2026.06.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。